A detailed history of Paragon Private Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Paragon Private Wealth Management, LLC holds 994 shares of LLY stock, worth $909,082. This represents 0.47% of its overall portfolio holdings.

Number of Shares
994
Previous 1,002 0.8%
Holding current value
$909,082
Previous $584,000 32.36%
% of portfolio
0.47%
Previous 0.42%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $4,737 - $6,338
-8 Reduced 0.8%
994 $773,000
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $9,978 - $11,763
19 Added 1.93%
1,002 $584,000
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $16,083 - $22,174
37 Added 3.91%
983 $527,000
Q1 2022

Jun 13, 2022

SELL
$234.69 - $291.66 $10,326 - $12,833
-44 Reduced 4.44%
946 $287,000
Q4 2021

Jun 08, 2022

BUY
$224.85 - $279.04 $222,601 - $276,249
990 New
990 $273,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paragon Private Wealth Management, LLC Portfolio

Follow Paragon Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Private Wealth Management, LLC with notifications on news.